{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T17:46:09Z","timestamp":1729619169935,"version":"3.28.0"},"reference-count":25,"publisher":"IEEE","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1109\/bibe.2012.6399769","type":"proceedings-article","created":{"date-parts":[[2013,1,7]],"date-time":"2013-01-07T21:34:59Z","timestamp":1357594499000},"page":"529-534","source":"Crossref","is-referenced-by-count":1,"title":["Design rules for cancer nanomedicines"],"prefix":"10.1109","author":[{"given":"Triantafyllos","family":"Stylianopoulos","sequence":"first","affiliation":[]},{"given":"Konstantinos","family":"Soteriou","sequence":"additional","affiliation":[]},{"given":"Dai","family":"Fukumura","sequence":"additional","affiliation":[]},{"given":"Rakesh K.","family":"Jain","sequence":"additional","affiliation":[]}],"member":"263","reference":[{"key":"19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","article-title":"Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes","volume":"268","author":"klibanov","year":"1990","journal-title":"FEBS Lett"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1340"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.2217\/17435889.3.5.703"},{"key":"15","first-page":"2335","article-title":"Neovascular targeting therapy: Paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy","volume":"9","author":"schmitt-sody","year":"2003","journal-title":"Clin Cancer Res"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2010.06.016"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1002\/aic.690330902"},{"key":"14","first-page":"1513","article-title":"Vascular permeability in a human tumour xenograft: Molecular charge dependence","volume":"82","author":"dellian","year":"2000","journal-title":"Br J Cancer"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/0026-2862(90)90023-K"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1006\/mvre.1996.2005"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20031253"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1016\/0169-409X(95)00039-A"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2008.30"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0600997103"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0801763105"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1007\/s10439-012-0630-4"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.8.4607"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2012.45"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.937"},{"key":"1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","article-title":"Delivering nanomedicine to solid tumors","volume":"7","author":"jain","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1200\/JCO.2001.19.14.3312","article-title":"Recurrent epithelial ovarian carcinoma: A randomized phase III study of pegylated liposomal doxorubicin versus topotecan","volume":"19","author":"gordon","year":"2001","journal-title":"J Clin Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.1998.16.7.2445","article-title":"Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial","volume":"16","author":"northfelt","year":"1998","journal-title":"J Clin Oncol"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1021\/nn900002m"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj0902015"},{"key":"9","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1200\/JCO.1996.14.8.2353","article-title":"Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma","volume":"14","author":"gill","year":"1996","journal-title":"J Clin Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/annonc\/mdh097","article-title":"Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX\/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer","volume":"15","author":"o'brien","year":"2004","journal-title":"Ann Oncol"}],"event":{"name":"2012 IEEE 12th International Conference on Bioinformatics & Bioengineering (BIBE)","start":{"date-parts":[[2012,11,11]]},"location":"Larnaca, Cyprus","end":{"date-parts":[[2012,11,13]]}},"container-title":["2012 IEEE 12th International Conference on Bioinformatics & Bioengineering (BIBE)"],"original-title":[],"link":[{"URL":"http:\/\/xplorestaging.ieee.org\/ielx5\/6387371\/6399636\/06399769.pdf?arnumber=6399769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T02:26:22Z","timestamp":1562552782000},"score":1,"resource":{"primary":{"URL":"http:\/\/ieeexplore.ieee.org\/document\/6399769\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1109\/bibe.2012.6399769","relation":{},"subject":[],"published":{"date-parts":[[2012,11]]}}}